Source: Υπουργείο Υγείας (CY) Revision Year: 2018 Publisher: MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
Nalion 0.25mg tablets.
Nalion 0.5mg tablets.
| Pharmaceutical Form |
|---|
|
Tablet. Nalion 0.25mg: white, round, flat scored tablets. Nalion 0.5mg: yellow, round, flat, scored tablets. The score line is not intended for breaking the tablet. |
Each tablet of Nalion 0.25mg contains 0.25mg of alprazolam.
Each tablet of Nalion 0.50mg contains 0.50mg of alprazolam.
Excipient with known effect: lactose.
Each tablet of Nalion 0.25mg includes 65.75mg lactose.
Each tablet of Nalion 0.5mg includes 70mg lactose.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Alprazolam |
Alprazolam, like other benzodiazepines, has a high affinity for the benzodiazepine binding site in the brain. It facilitates the inhibitory neurotransmitter action of gamma-aminobutyric acid, which mediates both pre- and post synaptic inhibition in the central nervous system (CNS). |
| List of Excipients |
|---|
|
Nalion 0.25 mg tablets also contain: Lactose Nalion 0.5 mg tablets also contain: Lactose |
Tablets are packaged in aluminium foil-polyvinylchloride blisters, with a patient information leaflet in a carton of 30 tablets.
Not all pack sizes may be marketed.
MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
Nalion 0.25mg tablets: 19847
Nalion 0.5mg tablets: 19848
Nalion 0.25mg tablets: Date of first authorization: 19/12/2005, Date of renewal: 31/08/2012
Nalion 0.5mg tablets: Date of first authorization: 19/12/2005, Date of renewal: 07/09/2011
| Drug | Countries | |
|---|---|---|
| NALION | Cyprus, Hong Kong |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
